Commercial Hemp In Canada

 

Health Canada

Tunney’s Pasture/
OTTAWA, Ontario
K1A 0L2

December 1, 1997
Publication of a Notice of Intent

Please be advised that the following Notice of Intent appears in the Canada
Gazette, Part I of:
DATE
December 6, 1997

SCHEDULE
Controlled Drugs and Substances Act – Amendment (Schedule No.1089)
Proposal for Industrial Hemp Regulations

Interested persons may make representations concerning the proposed
amendments to
the Responsible Officer, Policy Division, Health Protection Branch Building,
Address Locator 0702B1, Tunney’s Pasture, Ottawa, Ontario, K1A 0L2, within 30
days of the date of publication of this notice. All such representations should
cite Canada Gazette Part I, the date of publication of this notice and Schedule
No.1089.

Lauraine Begin
Policy Division
Attachments
DEPARTMENT OF HEALTH

CONTROLLED DRUGS AND SUBSTANCES ACT

Proposal for Industrial Hemp Regulations
Controlled Drugs and Substances Act – Amendment

This advance notice provides the public and Canada’s trading partners
with the opportunity to comment on a proposed regulatory framework for the
commercial cultivation of industrial hemp. It is Health Canada’s intention to
develop regulations that will permit the commercial cultivation of industrial
hemp in Canada, and make a consequential amendment to Schedule II under the
Controlled Drugs and Substances Act. Health Canada will endeavour to publish a
text of the Regulations and the amendment in Canada Gazette, Part I, before the
end of December, 1997.

It is proposed that the regulatory framework consist of the following:

— Importers and exporters of industrial hemp, in the form of seed or
grain, or derivatives of that seed or grain, will be licensed and each shipment
will require an individual permit. The use of such permits, for both
imports and
exports, will ensure compliance with the United Nations Single Convention on
Narcotics, 1961.
— The importer must ensure that each shipment of non pedigreed seeds, to
be used as grain, is accompanied by a document issued by a country or an
association of countries, designated by the Minister on a list published by the
Department of Health, indicating that the controls on the production of the
grain
meet requirements to ensure that it will not produce a plant containing
more than
0.3 per cent delta-9-tetrahydrocannabinol.

 Distributors of seeds will also be licensed.

 Growers will require a licence before they may purchase seeds from a
distributor or cultivate industrial hemp. Only pedigreed seeds may be planted.

 Licences will also be issued for processing activities such as pressing
seeds into oil.

 One precondition to obtaining a licence for any activity will be a
police security check, i.e., criminal record search.

 Derivatives of seed or grain, such as oil and seed cake, will be
exempted if they contain less than 10 micrograms of delta-9-tetrahydrocannabinol
per gram.

– 2 –

The proposed amendment includes a provision to modify the exclusion of
non-viable cannabis seeds contained in item number (8) of Schedule II to the
Controlled Drugs and Substances Act to clearly indicate that all derivatives are
controlled under the Controlled Drugs and Substances Act.

Individuals, businesses and trading partners interested in these
Regulations are invited to comment on the proposed framework. Additional
opportunities to comment on the Industrial Hemp Regulations will be
provided when
the regulations are published in Canada Gazette, Part I.Health Canada
Tunney’s Pasture/
OTTAWA, Ontario
K1A 0L2

December 1, 1997
Publication of a Notice of Intent

Please be advised that the following Notice of Intent appears in the Canada
Gazette, Part I of:
DATE
December 6, 1997

SCHEDULE
Controlled Drugs and Substances Act – Amendment (Schedule No.1089)
Proposal for Industrial Hemp Regulations

Interested persons may make representations concerning the proposed
amendments to
the Responsible Officer, Policy Division, Health Protection Branch Building,
Address Locator 0702B1, Tunney’s Pasture, Ottawa, Ontario, K1A 0L2, within 30
days of the date of publication of this notice. All such representations should
cite Canada Gazette Part I, the date of publication of this notice and Schedule
No.1089.

Lauraine Begin
Policy Division
Attachments
DEPARTMENT OF HEALTH

CONTROLLED DRUGS AND SUBSTANCES ACT

Proposal for Industrial Hemp Regulations
Controlled Drugs and Substances Act – Amendment

This advance notice provides the public and Canada’s trading partners
with the opportunity to comment on a proposed regulatory framework for the
commercial cultivation of industrial hemp. It is Health Canada’s intention to
develop regulations that will permit the commercial cultivation of industrial
hemp in Canada, and make a consequential amendment to Schedule II under the
Controlled Drugs and Substances Act. Health Canada will endeavour to publish a
text of the Regulations and the amendment in Canada Gazette, Part I, before the
end of December, 1997.

It is proposed that the regulatory framework consist of the following:

— Importers and exporters of industrial hemp, in the form of seed or
grain, or derivatives of that seed or grain, will be licensed and each shipment
will require an individual permit. The use of such permits, for both
imports and
exports, will ensure compliance with the United Nations Single Convention on
Narcotics, 1961.
— The importer must ensure that each shipment of non pedigreed seeds, to
be used as grain, is accompanied by a document issued by a country or an
association of countries, designated by the Minister on a list published by the
Department of Health, indicating that the controls on the production of the
grain
meet requirements to ensure that it will not produce a plant containing
more than
0.3 per cent delta-9-tetrahydrocannabinol.

 Distributors of seeds will also be licensed.

 Growers will require a licence before they may purchase seeds from a
distributor or cultivate industrial hemp. Only pedigreed seeds may be planted.

 Licences will also be issued for processing activities such as pressing
seeds into oil.

 One precondition to obtaining a licence for any activity will be a
police security check, i.e., criminal record search.

 Derivatives of seed or grain, such as oil and seed cake, will be
exempted if they contain less than 10 micrograms of delta-9-tetrahydrocannabinol
per gram.

– 2 –

The proposed amendment includes a provision to modify the exclusion of
non-viable cannabis seeds contained in item number (8) of Schedule II to the
Controlled Drugs and Substances Act to clearly indicate that all derivatives are
controlled under the Controlled Drugs and Substances Act.

Individuals, businesses and trading partners interested in these
Regulations are invited to comment on the proposed framework. Additional
opportunities to comment on the Industrial Hemp Regulations will be
provided when
the regulations are published in Canada Gazette, Part I.

Comments may be sent to: Jean Peart, Manager, Hemp Project, Bureau of
Drug Surveillance, Therapeutic Products Directorate, Health Canada, Address
Locator: 4103A, 122 Bank Street, 3rd Floor, Ottawa, Ontario, Canada K1A 1B9, or
by internet at: [email protected]

o/s

DANN M. MICHOLS
Director General
Therapeutic Products
Directorate

Date November 28, 1997

Comments